Uni-Bio Science Group Limited (HKG:0690)

Uni-Bio Science Group Revenue

Uni-Bio Science Group had revenue of 273.78M HKD in the half year ending June 30, 2026, with 0.06% growth. This brings the company's total for the last twelve months to 549.77M, down -6.75% year-over-year. In the year 2025, Uni-Bio Science Group had annual revenue of 586.21M with 6.01% growth. That makes Uni-Bio Science Group the 25,429th largest company in the world by revenue and 1,504th in Hong Kong.

• Revenue (ttm): 549.77M
• Revenue Growth: -6.75%
• P/S Ratio: 0.72
• Revenue / Employee: 967.90K
• Employees: 568
• Market Cap: 394.10M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Biological Pharmaceutical Products 386.45M 65.9%
• Chemical Pharmaceutical Products 199.76M 34.1%

Fiscal year ended Dec 31, 2025 See the full Uni-Bio Science Group breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	586.21M	33.23M	6.01%
Dec 31, 2024	552.98M	68.26M	14.08%
Dec 31, 2023	484.72M	44.40M	10.08%
Dec 31, 2022	440.32M	86.91M	24.59%
Dec 31, 2021	353.41M	144.63M	69.27%

Data Source: S&P Global Market Intelligence Last updated: Sep 18, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 2, 2026

Data Sources Report a data error